FMP
Shanghai HeartCare Medical Technology Corporation Limited
6609.HK
HKSE
Shanghai HeartCare Medical Technology Corporation Limited engages in the research, development, manufacture, and sale of neuro-interventional medical devices worldwide. The company offers ischemic stroke thrombectomy, intracranial stenosis treatment, ischemic stroke prevention, hemorrhagic stroke treatment, and vascular access devices. Its products are used for the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis, as well as for the treatment of hemorrhagic stroke. The company was formerly known as Shanghai Care Medical Technology Corporation Limited. Shanghai HeartCare Medical Technology Corporation Limited was incorporated in 2016 and is headquartered in Shanghai, the People's Republic of China.
32.7 HKD
0.45 (1.38%)
Valuation Date:
Mar 18, 2025 3:37 AM
Share Price on Valuation Date
$32.7
Stock Beta
0.754
Shares Outstanding
38773788